LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Uždarymo kaina

2.53 -3.44

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.4699999999999998

Max

2.62

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-77K -3.6M
Darbuotojai	20
EBITDA	-79K -3.6M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+184.09% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	43M 183M
Ankstesnė atidarymo kaina	5.97
Ankstesnė uždarymo kaina	2.53

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-20 17:19; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

2026-03-20 16:45; UTC

Svarbiausios naujienos

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

2026-03-20 16:22; UTC

Svarbiausios naujienos

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

2026-03-20 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 20:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 19:55; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Brent Crude Closes Out Volatile Week Higher -- Market Talk

2026-03-20 19:28; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

2026-03-20 19:28; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 18:39; UTC

Rinkos pokalbiai

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

2026-03-20 18:31; UTC

Įsigijimai, susijungimai, perėmimai

Honeywell Announces Pricing of Debt Tender Offers >HON

2026-03-20 18:19; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- Update

2026-03-20 18:15; UTC

Rinkos pokalbiai

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

2026-03-20 17:57; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Inches Up -- Market Talk

2026-03-20 17:04; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

2026-03-20 16:20; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 16:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 15:40; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

2026-03-20 15:30; UTC

Uždarbis

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

2026-03-20 15:26; UTC

Rinkos pokalbiai

Uždarbis

Svarbiausios naujienos

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

2026-03-20 15:26; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

2026-03-20 15:25; UTC

Rinkos pokalbiai

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

2026-03-20 15:19; UTC

Rinkos pokalbiai

Svarbiausios naujienos

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

2026-03-20 14:58; UTC

Svarbiausios naujienos

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

2026-03-20 14:55; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Lower as Speculative Pullback Extends -- Market Talk

2026-03-20 14:54; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 14:53; UTC

Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

2026-03-20 14:46; UTC

Rinkos pokalbiai

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

2026-03-20 14:45; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

184.09% į viršų

12 mėnesių prognozė

Vidutinis 7.5 USD 184.09%

Aukščiausias 12 USD

Žemiausias 5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.